Komori
Lihit Lab. (7975) · RiskRestated

Risk of Breaching Financial Covenants in Borrowing Agreements

First written in FY2024. 5 of 7 entries say "Restated". Latest entry: FY2027-H1.

7entries
3years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2024 – FY2027-H12024: 320242025: 120252026: 32026
Same theme, other companies
Risk of Loss of the Benefit of Time Due to Breach of Financial CovenantsA theme 291 companies write about · 295 as a headwind · 0 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 196 companies compared. The sentences above are computed from all 196.Comparing 200 of the theme's 297 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2027-H1RestatedAnnual report

    「The commitment line agreement entered into by the Company on 25 February 2026 is subject to the following financial covenants.」

    The company continues to disclose the covenants under the commitment line agreement entered into on 25 February 2026, requiring it to maintain net assets at 75% or more, avoid operating losses for 2 consecutive periods, and keep interest-bearing debt at or below net assets. The ¥1,000 million commitment line remains entirely undrawn.
  2. FY2026Financial covenants under the new commitment line agreementAnnual report

    「The commitment line agreement entered into by the Company on 25 February 2026 is subject to the following financial covenants.」

    The company has disclosed financial covenants under the newly executed commitment line agreement, including maintaining net assets at 75%, avoiding operating losses for 2 consecutive fiscal periods and maintaining interest-bearing debt at no more than net assets.
  3. 2026-04-28RestatedGeneral Meetings of Shareholders

    「(2) The commitment line agreement entered into by the company on 25 February 2026, with a borrowing limit of ¥1,000,000 thousand and no outstanding borrowings, contains the following financial covenants.」

    The company discloses the borrowing limit and financial covenants under the commitment line agreement, continuing its disclosure of risks related to financial covenants.
  4. FY2025RestatedAnnual report

    「Certain borrowing agreements of the Group are subject to financial covenants. If the Group breaches any financial covenant in the future, it may lose the benefit of time and be required to repay the relevant borrowings in full, which could affect the Group's financial condition and operating results.」

    The company continues to disclose the risk that a breach of financial covenants could result in the loss of the benefit of time and a demand for repayment in full.
  5. FY2025-H1RestatedAnnual report

    「Regarding (3), the company was in breach of the financial covenants at the end of the previous consolidated fiscal year, but obtained the lending banks' consent to continue the agreement.」

    The company continues to disclose the breach, as of the end of the previous consolidated fiscal year, of the financial covenant concerning operating profit or loss under its committed term loan, as well as the banks' consent to continue the agreement.
  6. FY2025-Q1RestatedAnnual report

    「Regarding (3), the company was in breach of the financial covenants at the end of the previous consolidated fiscal year, but obtained the lending banks' consent to continue the agreement.」

    The company continues to disclose the breach, as of the end of the previous consolidated fiscal year, of the financial covenant concerning operating profit or loss under its committed term loan, as well as the banks' consent to continue the agreement.
  7. FY2024First statedAnnual report

    「Regarding (3), the company was in breach of the financial covenants at the end of the current consolidated fiscal year, but obtained the lending banks' consent to continue the agreement.」

    The company has disclosed an actual breach of the financial covenant under its committed term loan agreement requiring it not to report operating losses for 2 consecutive fiscal periods. The agreement also includes requirements to maintain net assets at 75% or more and interest-bearing debt at no more than net assets, and the company has obtained the banks' consent to continue the agreement.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Lihit Lab. yet. It last moved in the General Meetings of Shareholders of 2026-04-28: "Restated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.